Epigenetic profiling in peripheral blood mononuclear cells and in immune cell subtypes, i.e. CD4+ and CD8+ T cells, suggests global differences in DNA methylation between MS patients and healthy controls [8–12]. Here, CD4 is linked to myeloid sarcoma.